Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis

Antimicrob Agents Chemother. 1989 May;33(5):767-70. doi: 10.1128/AAC.33.5.767.

Abstract

We evaluated the activities of ceftriaxone (15 mg/kg), netilmicin (6 mg/kg), and their combination given intramuscularly once daily for 4 days for the treatment of experimental Escherichia coli endocarditis in rabbits. In vitro, a greater rate of killing and an increased trough serum bactericidal titer (P less than 0.01) were achieved with the combination. In vivo, the combination had a greater bactericidal effect (P less than 0.01) and resulted in a greater number of sterile vegetations (P less than 0.05) than single-drug therapy. Thus, in vivo, an increased effect can be obtained despite a single daily dose of a long-acting cephalosporin and an aminoglycoside.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ceftriaxone / pharmacokinetics
  • Ceftriaxone / therapeutic use*
  • Drug Combinations
  • Endocarditis, Bacterial / drug therapy*
  • Endocarditis, Bacterial / microbiology
  • Escherichia coli Infections / drug therapy*
  • Escherichia coli Infections / microbiology
  • Female
  • Half-Life
  • Humans
  • Male
  • Netilmicin / pharmacokinetics
  • Netilmicin / therapeutic use*
  • Rabbits

Substances

  • Drug Combinations
  • Netilmicin
  • Ceftriaxone